• 尊龙凯时

    SynRx
    SynRx
    SynRx
    SynRx SynRx
    Using synthetic lethality strategy to target tumor cells with DNA damage repair defects
    Science Pipeline Technology
    Pipeline
    Target
    Positioning
    Discovery
    Hit-to-Lead
    Lead
    Optimization
    IND
    Enabling
    Clinical Trials
    Anticipated Milestones
    • SY001
      HRD solid cancers
      IND filing 2023
    • SY002
      HRD solid cancers
      IND filing 2023
    • SY003
      Solid cancers
      Development candidate in 2023
    • SY004
      Solid cancers
      Development candidate in 2023
    • SY005
      Solid cancers
      Development candidate in 2023
    SynRx
    Business Development bd@mini818.com
    Careers hr@mini818.com
    Address @ Room 201, Building 4, 1390 Cangxing Street, Cangqian Subdistrict, Yuhang District, Hangzhou, Zhejiang @ Room 303, No.1, Lane 88, Shengrong Road, Zhangjiang High-Tech Park, Pudong New District, Shanghai
    CopyRight 2022 All Right Reserved SynRx Therapeutics 浙ICP备2021033925号 SiteMap
    SynRx
    SynRx
    SynRx
    0571-86360796
    SynRx